Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission 
tomography/computed tomography in the follow-up of medullary thyroid carcinoma

Luster, Markus; Karges, Wolfram; Zeich, Katrin; Pauls, Sandra; Verburg, Frederik A.; Dralle, Henning; Glatting, Gerhard; Buck, Andreas K.; Solbach, Christoph; Neumaier, Bernd; Reske, Sven N.; Mottaghy, Felix M.

doi:10.1089/thy.2009.0342

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma

MPS-Authors

/persons/resource/persons147249

Neumaier, Bernd
Radiochemistry, Scientific Services and Development, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Luster, M., Karges, W., Zeich, K., Pauls, S., Verburg, F. A., Dralle, H., et al. (2010). Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma. Thyroid, 20(5), 527-533. doi:10.1089/thy.2009.0342.

Cite as: https://hdl.handle.net/11858/00-001M-0000-0026-D319-6